Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity

Published:2017-01-06 Issue:4 Volume:16 Page:264-272
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Lesterhuis W. Joost,Bosco Anthony,Millward Michael J.,Small Michael,Nowak Anna K.,Lake Richard A.

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd.2016.233.pdf

Reference125 articles.

1. Poincarre, H. Science and Method (T. Nelson, London, 1914).

2. Wolchok, J. D. et al. Nivolumab plus ipilimumab in advanced melanoma. N. Engl. J. Med. 369, 122–133 (2013).

3. Robert, C. et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med. 364, 2517–2526 (2011).

4. Garon, E. B. et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N. Engl. J. Med. 372, 2018–2028 (2015).

5. Motzer, R. J. et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N. Engl. J. Med. 373, 1803–1813 (2015).

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer;Cancers;2024-08-08

2. CD47-mediated immune evasion in early-stage lung cancer progression;Biochemical and Biophysical Research Communications;2024-08

3. Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores;The Lancet Diabetes & Endocrinology;2024-07

4. Exploiting temporal aspects of cancer immunotherapy;Nature Reviews Cancer;2024-06-17

5. Exploration of a noninvasive radiomics classifier for breast cancer tumor microenvironment categorization and prognostic outcome prediction;European Journal of Radiology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3